Mutating factor VIII: lessons from structure to function

被引:44
作者
Fay, PJ
Jenkins, PV
机构
[1] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA
[3] Royal Free Hosp, Katharine Dormandy Haemophilia Ctr, London NW3 2QG, England
[4] Royal Free Hosp, Haemostasis Unit, London NW3 2QG, England
关键词
factor VIII; factor VIIIa; factor IXa; intrinsic factor Xase; site-directed mutagenesis; CRM+ hemophilia;
D O I
10.1016/j.blre.2004.02.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor VIII, a metal ion-dependent heterodimer, circulates in complex with von Willebrand factor. At sites of vessel wall damage, this procofactor is activated to factor Villa by limited proteolysis and assembles onto an anionic phospholipid surface in complex with factor Na to form the an enzyme complex that efficiently converts factor X to factor Xa during the propagation phase of coagulation. Factor Xase activity is down-regulated by mechanisms that include self-dampening by dissociation of a critical factor Villa subunit and proteolytic inactivation by the activated protein C pathway. Recent studies identify putative metal ion coordination sites as well as ligands involved in the catabolism of the activated and procofactor forms of the protein. Our knowledge of these multiple intra- and inter-molecular interactions has been facilitated by the application of naturally occurring and site-directed mutations to study factor VIII structure and function. In this review, we document important and novel contributions following this line of investigation. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:15 / 27
页数:13
相关论文
共 88 条
[1]   HEMOPHILIA-A DUE TO MUTATIONS THAT CREATE NEW N-GLYCOSYLATION SITES [J].
ALY, AM ;
HIGUCHI, M ;
KASPER, CK ;
KAZAZIAN, HH ;
ANTONARAKIS, SE ;
HOYER, LW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) :4933-4937
[2]   The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII [J].
Amano, K ;
Sarkar, R ;
Pemberton, S ;
Kemball-Cook, G ;
Kazazian, HH ;
Kaufman, RJ .
BLOOD, 1998, 91 (02) :538-548
[3]   Factor IXa:factor VIIIA interaction -: Helix 330-338 of factor IX interacts with residues 558-565 and spatially adjacent regions of the A2 subunit of factor VIIIa [J].
Bajaj, SP ;
Schmidt, AE ;
Mathur, A ;
Padmanabhan, K ;
Zhong, DG ;
Mastri, M ;
Fay, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :16302-16309
[4]   Antigenicity of putative phospholipid membrane-binding residues in factor VIII [J].
Barrow, RT ;
Healey, JF ;
Jacquemin, MG ;
Saint-Remy, JMR ;
Lollar, P .
BLOOD, 2001, 97 (01) :169-174
[5]   Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules [J].
Barrow, RT ;
Healey, JF ;
Gailani, D ;
Scandella, D ;
Lollar, P .
BLOOD, 2000, 95 (02) :564-568
[6]  
BARROW RT, 1994, J BIOL CHEM, V269, P593
[7]  
BARROWCLIFFE TW, 1984, SCAND J HAEMATOL, V33, P39
[8]   COPPER-ATOM IDENTIFICATION IN THE ACTIVE AND INACTIVE FORMS OF PLASMA-DERIVED FVIII AND RECOMBINANT FVIII-DELTA-II [J].
BIHOREAU, N ;
PIN, S ;
DEKERSABIEC, AM ;
VIDOT, F ;
FONTAINEAUPART, MP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 222 (01) :41-48
[9]   Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII [J].
Bovenschen, N ;
Boertjes, RC ;
van Stempvoort, G ;
Voorberg, J ;
Lenting, PJ ;
Meijer, AB ;
Mertens, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9370-9377
[10]   X-RAY STRUCTURE OF CLOTTING FACTOR IXA - ACTIVE-SITE AND MODULE STRUCTURE RELATED TO XASE ACTIVITY AND HEMOPHILIA-B [J].
BRANDSTETTER, H ;
BAUER, M ;
HUBER, R ;
LOLLAR, P ;
BODE, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9796-9800